AFFITOPE AD02

BIOLOGICAL2 trials

Sponsors

Affiris AG

Conditions

Alzheimer's Disease

Phase 1

Tolerability and Safety of Subcutaneous Administration of AFFITOPE AD02 in Mild to Moderate Alzheimer's Disease

CompletedNCT00633841

Affiris AGAlzheimer's Disease

Start: 2008-02-29End: 2009-09-30Updated: 2010-10-19

Safety/Tolerability, Immunological and Clinical Activity of a Boost Immunization With AFFITOPE AD02

CompletedNCT01093664

Affiris AGAlzheimer's Disease

Start: 2009-10-31End: 2010-07-31Updated: 2010-10-19